Emerging Roles of Megakaryocytes in Immune Regulation and Potential Therapeutic Prospects
Cells · 27.10.2025 · 14 (21) · 1677
DOI: 10.3390/cells14211677 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 27.10.2025. Verfasst von Seungjun Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yongin 449-791, Republic of Korea. Hauptthemen laut MEDLINE: Megakaryocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Hankuk University of Foreign Studies Research Fund.
Abstract (Originalsprache)
Megakaryocytes (MKs) have traditionally been viewed as terminal hematopoietic cells responsible solely for platelet production. However, recent advances in imaging and single-cell transcriptomics have revealed substantial heterogeneity among MK populations and diverse functions beyond thrombopoiesis. MKs actively participate in innate and adaptive immunity, modulate the hematopoietic stem cell (HSC) niche, and adapt to physiological and pathological stimuli. Located in distinct anatomical sites such as bone marrow and lung, MKs exhibit compartment-specific specializations that enable them to serve as critical integrators of hemostatic, immune, and regenerative processes. Experimental models using human pluripotent stem cells and inducible MKs have enhanced mechanistic insights, while innovative bioreactor platforms and xenotransplantation strategies advance translational applications in platelet production and therapy. Furthermore, immune MK subsets derived from pluripotent stem cells show promising therapeutic potential for modulating inflammation and autoimmune diseases. Continued exploration of MK diversity, tissue-specific roles, and intercellular communication will unlock new opportunities for leveraging MK plasticity in regenerative medicine, immunotherapy, and hematologic disorders, repositioning these versatile cells as central players in systemic homeostasis and defense.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yongin 449-791, Republic of Korea.
ORCID-Profile: Seungjun Kim, Kiwon Lee
Förderung
- National Research Foundation of Korea
- Hankuk University of Foreign Studies Research Fund
Zitieren
APA
Kim, S., & Lee, K. (2025). Emerging Roles of Megakaryocytes in Immune Regulation and Potential Therapeutic Prospects. Cells, 14(21), 1677. https://doi.org/10.3390/cells14211677
Vancouver
Kim S, Lee K. Emerging Roles of Megakaryocytes in Immune Regulation and Potential Therapeutic Prospects. Cells. 2025;14(21):1677. doi:10.3390/cells14211677
BibTeX
@article{Kim2025,
author = {Kim, Seungjun and Lee, Kiwon},
title = {Emerging Roles of Megakaryocytes in Immune Regulation and Potential Therapeutic Prospects},
journal = {Cells},
year = {2025},
volume = {14},
number = {21},
pages = {1677},
doi = {10.3390/cells14211677}
}
EUVIMED